KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Patrick Treanor
KalVista Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
About Patrick Treanor
KalVista Pharmaceuticals, Inc. reported in an 8-K filed June 11, 2026 that Patrick Treanor resigned as member of the Company's board of directors. KalVista Pharmaceuticals, Inc. reported in an 8-K filed October 17, 2022 that Patrick Treanor was appointed member of the Compensation Committee, effective October 13, 2022. KalVista Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof”
“the Board approved the appointment of Nancy Stuart as the Chair of the Nominating and Corporate Governance Committee and Patrick Treanor as a member of the Compensation Committee.”
Affiliation history
-
KalVista Pharmaceuticals, Inc.
SEC 8-K
Current2022-10-13–present
-
KalVista Pharmaceuticals, Inc.
Board Member
Proxy statement
Start not stated–2026-06-11
Company network
Recent activity
-
Executive change Resigned: member of the Company's board of directors
KalVista Pharmaceuticals, Inc.
-